Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: Short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen

International Journal of Infectious Diseases

Volumn 33, Issue , 2015, Pages e132-e134

  Oliva, Alessandra ^a   Mascellino, Maria T ^a   Cipolla, Alessia ^a   D'Abramo, Alessandra ^a   De Rosa, Annalisa ^a   Savinelli, Stefano ^a   Ciardi, Maria Rosa ^a   Mastroianni, Claudio M ^a,b   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bloodstream infection; Colistin; Double carbapenem; Pan drug resistant K. pneumoniae

Indexed keywords

C REACTIVE PROTEIN; CARBAPENEM; COLISTIN; DAPTOMYCIN; DOUBLE CARBAPENEM; ERTAPENEM; GENTAMICIN; GLYCOPEPTIDE; MEROPENEM; METICILLIN; QUINOLONE DERIVATIVE; RIFAMPICIN; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ACINETOBACTER BAUMANNII; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLOODSTREAM INFECTION; CASE REPORT; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HALLUCINATION; HUMAN; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LOADING DRUG DOSE; MINIMUM INHIBITORY CONCENTRATION; PANDRUG RESISTANT KLEBSIELLA PNEUMONIAE; SHORT COURSE THERAPY; TACHYCARDIA; TREATMENT DURATION; VISUAL HALLUCINATION; DRUG COMBINATION; DRUG EFFECTS; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 84922460569     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.01.011     Document Type: Article

References (6)

1. Capone A., Giannella M., Fortini D., Giordano A., Meledandri M., Ballardini M., et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013, 19:E23-E30. SEERBIO-GRAB Network.
2. Tascini C., Tagliaferri E., Giani T., Leonildi A., Flammini S., Casini B., et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2013, 57:3990-3993.
3. Oliva A., D'Abramo A., D'Agostino C., Iannetta M., Mascellino M.T., Gallinelli C., et al. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Chemother 2014, 69:1718-1720.
4. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard: ninth edition. M07-A9. Wayne, PA: CLSI; 2012.
5. Giske C.G., Gezelius L., Samuelsen Ø., Warner M., Sundsfjord A., Woodford N. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 2011, 17:552-556.
6. Falagas M.E., Kasiakou S.K. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006, 10:R27.